尿微量白蛋白与代谢综合征胰岛素抵抗的关系探讨(4)
 |
| 第1页 |
参见附件(3386KB，4页)。
[2] Hyo Sun Choia,Seung Ho Ryub,Kyu-Beck Leea.The Relationship of Microalbuminuria with Metabolic Syndrome.Nephron Clin Pract,2006,104:85-93.
[3] Basi S,Fesler P,Mimran A,Lewis JB.Microalbuminuria in type 2 diabetes and hypertension:a marker,treatment target,or innocent bystander.Diabetes Care,2008,31(Suppl2):194-201.
[4] Qiao Q,Gao W,Zhang L,et al.Metabolic syndrome and cardiovascular disease.Ann Clin Biochem,2007,44:232-263.
[5] Grundy SM,Cleeman JI,Daniels SR,et al.Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart,Lung,and Blood Institute Scientific Statement.Circulation,2005,112:2735-2752.
[6] Palaniappan L,Carnethon M,Fortmann SP Association between microalbuminuria and the metabolic syndrome:NHANES III.Am J Hypertens,2003,16:952-958.
[7] 周新,涂植光.临床生物化学和生物化学检验.人民卫生出版社,2003:273-274.
[8] 李霞,周智广,元海英,等.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能.中南大学学报(医学版),2004,29(4).
[9] Ito Y,Utsugi T,Ohyama Y,et al.Role of blood pressure in the progression of microalbuminuria in elderly Japanese type 2 patients:a 7-year followup stydy.J Int Med Res,2001,29:280-286.
[10] Kirpichnikov D,Sowers JR.Diabetes mellitus and diabetes associated vascular disease.Endocrinology &Metabolism,2001,12:255-258.
[11] Enzo B,Gisnni F,Francesco C,et al.HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects.Diabetes Care,2002,25:1135-1141.
[12] Grundy SM J。Metabolic syndrome:a multiplex cardiovascular risk factor ......
您现在查看是摘要介绍页，详见PDF附件(3386KB，4页)。